Researchers are establishing study groups based on high concentrations of interferon-alpha (IFN-α) – exceeding 5 U/ml – found in cord blood, a finding that could refine understanding of immune system development and response.
IFN-α, a naturally occurring protein, is crucial in the body’s antiviral defense. The pharmaceutical form, interferon alfa, is derived from human blood leukocytes induced with Sendai virus and purified through affinity chromatography, according to pharmaceutical information. It is currently used in the treatment of several cancers, including leukemia and melanoma, as well as hepatitis B and C.
The focus on cord blood IFN-α levels stems from observations that progenitors within cord blood demonstrate a significantly greater capacity to develop into plasmacytoid dendritic cells (pDCs) compared to those found in bone marrow. These pDCs, upon stimulation, upregulate molecules that activate T cells, but exhibit impaired production of IFN-α for up to nine months after cord blood transplantation, research indicates.
The activity of different IFN-α subtypes, of which there are 14 individual genes and allelic variants, is not fully understood. Studies suggest that variations in amino acid composition among these subtypes may result in differing affinities for receptors and varying levels of biological activity. While IFN-α proteins are diverse, their functional impact remains an area of ongoing investigation.
Ropeginterferon alfa-2b, a monopegylated form of interferon, is currently approved for the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis. However, data regarding its safety during pregnancy and lactation remain limited.
Common side effects associated with interferon alfa treatment include increased risk of infection due to reduced white blood cell counts, sleep disturbances, mood changes, headaches, dizziness, gastrointestinal issues, hair loss, and fatigue. The U.S. Food and Drug Administration has issued a “black box warning” regarding the potential for severe neuropsychiatric, autoimmune, ischemic, and infectious disorders.
Leave a Reply